Practical Investing

Follow columnist Kathy Kristof as she shares lessons from her real-life investment portfolio.

From Kiplinger's Personal Finance, December 2017

Why I Think Apple's Stock Is a Bargain

Though Apple is already largest holding in my portfolio, I'm sorely tempted to buy more.

See More On: Tech Stocks | Stocks & Bonds

From Kiplinger's Personal Finance, November 2017

Investors, Don't Let Current Events Spook You

It may seem like you’re facing the storm of the century every time you turn on the news, but the markets have survived far worse.

See More On: Stocks & Bonds | Economic Forecasts

From Kiplinger's Personal Finance, September 2017

I Add Two Bargains to My Portfolio

One pick, Lazard, is a global investment banking firm. Its reasonable share price provides a margin of safety.

See More On: Stocks & Bonds | Saving for Retirement

From Kiplinger's Personal Finance, June 2017

Is Intel's Buying Binge a Good Thing?

Intel’s purchase of Mobileye is its second mega-deal in the past two years, but Intel doesn’t have a stellar history when it comes to big acquisitions.

See More On: Stocks & Bonds | Tech Stocks

From Kiplinger's Personal Finance, May 2017

Can This Fallen Biotech Be Revived?

I've been sorely tempted to sell my Gilead shares. But now that they're cheaper, maybe I should buy more.

See More On: Stocks & Bonds | Tech Stocks

From Kiplinger's Personal Finance, February 2017

This Stumbling Biotech Stock Still Has a Lot of Promise

Gilead Sciences' robust product pipeline should turn things around.

See More On: Stocks & Bonds | Tech Stocks

From Kiplinger's Personal Finance, January 2017

My Portfolio's Uninvited Guests

A well-considered spin-off can increase the value of both parent and child by allowing each to focus on a narrower set of goals.

See More On: Stocks & Bonds

From Kiplinger's Personal Finance, December 2016

Why Is My Portfolio Lagging? Blame It on 2015

A portfolio without FANGs was doomed to have trouble last year.

See More On: Stocks & Bonds

From Kiplinger's Personal Finance, November 2016

Learning From My Misguided Attempt to Beat the Market

Selling quality stocks was just one of the mistakes.

See More On: Investor Psychology

From Kiplinger's Personal Finance, October 2016

How Doing Nothing Can Pay Off for Investors

For the three-month period during which I essentially ignored my investments, the Practical Investing portfolio rose 10%.

See More On: Stocks & Bonds | Investor Psychology

From Kiplinger's Personal Finance, July 2016

AV Homes: A Cheap Stock With Rich Potential

This small homebuilder's first-quarter results were impressive, with big gains in number of dwellings sold and other key measures.

See More On: Stocks & Bonds

From Kiplinger's Personal Finance, June 2016

Biotech Giant Gilead Sciences Goes on Sale

Gilead Sciences stock was selling for a mere 7 times estimated 2016 earnings when I snapped up 150 shares.

See More On: Stocks & Bonds | Tech Stocks

From Kiplinger's Personal Finance, May 2016

Don't Let the Day's News Drive Your Investing

Constantly checking market results practically begs you to do something, even if doing nothing is the best course.

See More On: Investor Psychology

From Kiplinger's Personal Finance, April 2016

Why I Keep Buying Apple Stock

Because I'm a diehard bargain hunter, I find Apple's stock too cheap to pass up.

See More On: Stocks & Bonds | Tech Stocks

From Kiplinger's Personal Finance, March 2016

More Lessons on Selling Your Stocks

I never should have owned Sohu, the Chinese Internet stock, in the first place. Buying it was a rash move.

See More On: Stocks & Bonds | Tech Stocks

From Kiplinger's Personal Finance, February 2016

How Losing Stocks Are Like Ex-Spouses

It took me 16 years to leave my ex. But I wanted to get divorced from my hurtful investments more quickly, so I called a couple of financial therapists.

See More On: Stocks & Bonds | Investor Psychology

From Kiplinger's Personal Finance, January 2016

Key to Investing Success: Knowing When to Sell Your Stocks

I own several stocks I should have sold, but a stubborn adherence to a buy-and-hold philosophy prevented me from pulling the trigger.

See More On: Stocks & Bonds | Mutual Funds

Show More Stories